COAGUCHEK ® XS SYSTEM
Report
- Report Number
- 1823260-2017-02156
- Event Type
- Malfunction
- Date Received
- September 29, 2017
- Date of Event
- September 13, 2017
- Report Date
- November 6, 2017
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- GJS
- PMA / PMN Number
- K062925
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PATIENT
Narratives
(B)(4).
NO PRODUCT WAS RETURNED BY THE CUSTOMER; THEREFORE NO FURTHER INVESTIGATION WAS POSSIBLE. NONE OF THE GIVEN TREATMENTS/MEDICATIONS ARE CURRENTLY KNOWN TO INTERFERE WITH THE ACCURACY OF THE TEST RESULTS.
THE CUSTOMER RECEIVED A QUESTIONABLE HIGH RESULT FROM COAGUCHEK XS METER SERIAL NUMBER (B)(4). THE RESULT AT 12:47 PM WAS 2.4 INR AND THE RESULT AT 12:51 PM WAS 1.9 INR. THE CUSTOMER STATED SHE SQUEEZED MORE BLOOD OUT OF THE SAME FINGERSTICK FOR THE SECOND TEST. THE CUSTOMER WAS ADVISED TO ALWAYS USE A NEW STICK AND A NEW FINGER FOR EACH TESTING. THE CUSTOMER WAS ANEMIC AND WAS ADVISED OF THE LIMITATIONS. SHE WAS NOT ON HEPARIN, HAD NO ANTIPHOSPHOLIPID ANTIBODIES, AND HAD NO CHANGE IN COUMADIN. THE CUSTOMER HAD NO NEW MEDICATIONS, NO CHANGE IN DIET. SHE HAD A MIGRAINE ON (B)(6) 2017. THE THERAPEUTIC RANGE WAS 3.0-4.0 INR. NO TREATMENT WAS BASED ON THE RESULTS AND THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE SUSPECT METER AND STRIPS WERE REQUESTED TO BE RETURNED FOR INVESTIGATION. RELEVANT RETENTION TEST STRIPS (LOT 223855) WERE TESTED IN COMPARISON WITH THE CURRENT MASTER LOT COAGUCHEK XS PT TEST STRIP (LOT 124158-80). FOR THIS PURPOSE TWO HUMAN BLOOD SAMPLES FROM (B)(6) DONORS AND TWO INTERNAL REFERENCE METERS WERE USED. NO ERROR MESSAGES OCCURRED. RETENTION SAMPLES WERE ACCEPTABLE AND RETENTION MATERIAL PERFORMED AS SPECIFIED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 684525 | COAGUCHEK ® XS SYSTEM | PROTHROMBIN TIME TEST STRIPS | GJS | ROCHE DIAGNOSTICS | NA | 22385523 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR |